News

Ideas That Generate Results

Technological Advancements Assisting the Growth of Global DNA Vaccines Market

Sep 19, 2016

Share |
According to a new research report by RNCOS entitled, “Global DNA Vaccine Market Outlook 2022”, current year has witnessed an emergence of potential DNA vaccine candidates manufactured by rDNA technology. These can help to suppress the chronic diseases with higher efficacy. For instance, Bexsero has in recent times entered into the market after successfully clearing the clinical trials. The key players in DNA vaccine industry are having numerous potential DNA vaccines in their pipeline which are undergoing clinical trials.
 
Clinical Trials are having a major focus on the prophylactic and therapeutic DNA vaccines for humans and this segment can be expected to evolve at a faster pace in the coming years. Nevertheless, progressive studies for developing new vaccines for treatment of most prevalent infectious diseases present globally are making it possible for the expansion of Global DNA Vaccines Market. Amidst the various research studies, a DNA vaccine for Meningococcal infection can be expected to enter soon into the market with promising candidate such as rMenB having entered phase 3 trial.
 
Research also showed that amongst the 2 types of DNA vaccines, recombinant protein vaccines are more prevalent that are used by humans. The study also concluded that the use of DNA vaccines in combination with additional therapies is driving the growth of DNA vaccines market across the world. Geographical analysis also revealed that the DNA vaccines are more common in North America and Europe.
 
Further adding to the recent developments in the DNA vaccine industry, researchers concluded that innovative methods of delivery of DNA vaccines is ought to increase its efficacy. The study also concluded that plasmid DNA delivered through intramuscular Electroporation induced convincing systemic cellular responses to the vaccine antigen. Adding to the advancing technologies, researchers are coming up with needle-free injection devices for higher immunogenicity of DNA Vaccines.
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM849.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


Media Citation

get in touch

Please fill-in the information below.